Cancer and aging are some of the scientific mysteries that are yet to be solved. However, Mikhail Blagosklonny has dedicated his research to finding out more about these two. He is based at the Roswell Park Cancer Institute as a professor of Oncology. He joined the institution in 2009 and was received with great enthusiasm by the staff at the institution. He also conducts research on cancer in search of new treatments and advancement of the existing ones. For instances, he realized that chemotherapy and radioactive rays that patients are exposed to tend to damage their cells. He is now working on therapies to protect the body cells from such damage.
He is also interested in aging. He uses his hypothesis based on the hyper-function theory to explain why aging happens. He argues that Target Of Rapamycin (TOR) is responsible for aging in organisms. The reason is that as the organisms continue to grow body cells are unable to adequately take up nutrients thus leading to their damage. Mikhail Blagosklonny also noticed that rapamycin which is common in cancer drugs reduces the damage of body cells. He proposed that this substance can be used as a remedy for aging. Further, through carrying out experiments on signal transduction, he has enable to reveal ways to slow down the aging process and also prevent age related illnesses. View Mikhail’s profile in LinkedIn
Blagosklonny holds an M.D in internal medicine from First Pavlov States Medical University of St. Peterburg. He also holds a PhD in cardiology and experimental medicine from the same institution. He has been a professor for quite a long time having started in 2002. He first worked as an associate professor in medicine at the New York Medical College. He also had a chance to work with Ordway Research Institute.
Blagosklonny is the editor-in-chief of Oncotarget. This is a biomedical journal that if freely accessible to all. Through the journal he has been able to make scientific knowledge especially in Oncology widely known rapidly. He has also enabled authors of various papers to come together to challenge and complement each other’s ideas. He is also an editor of International Journal of Cancer, American Journal of Pathology and Cell death and differentiation. Follow Mikhail on Loop